BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11859737)

  • 21. Non-steroidal anti-inflammatory drugs and molecular carcinogenesis of colorectal carcinomas.
    Huls G; Koornstra JJ; Kleibeuker JH
    Lancet; 2003 Jul; 362(9379):230-2. PubMed ID: 12885487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Colorectal cancer chemoprevention].
    Starzyńka T; Wasilewicz MP
    Pol Merkur Lekarski; 2007 Jul; 23(133):70-3. PubMed ID: 18051834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?
    Alberts DS; Hixson L; Ahnen D; Bogert C; Einspahr J; Paranka N; Brendel K; Gross PH; Pamukcu R; Burt RW
    J Cell Biochem Suppl; 1995; 22():18-23. PubMed ID: 8538196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cyclooxygenase as a target for colorectal cancer chemoprevention.
    Moreira L; Castells A
    Curr Drug Targets; 2011 Dec; 12(13):1888-94. PubMed ID: 21158711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low dose aspirin, COX-inhibition and chemoprevention of colorectal cancer.
    Benamouzig R; Uzzan B; Little J; Chaussade S
    Curr Top Med Chem; 2005; 5(5):493-503. PubMed ID: 15974944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: chemoprevention of colorectal cancer.
    Courtney ED; Melville DM; Leicester RJ
    Aliment Pharmacol Ther; 2004 Jan; 19(1):1-24. PubMed ID: 14687163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemoprevention of familial cancer].
    Ishikawa H
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):951-7. PubMed ID: 9212803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colon cancer: preventive agents and the present status of chemoprevention.
    Half E; Arber N
    Expert Opin Pharmacother; 2009 Feb; 10(2):211-9. PubMed ID: 19236194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclo-oxygenase inhibition in colorectal adenomas and cancer.
    Ricchi P; Pignata S; Iaffaioli RV; Daniele B
    J Clin Gastroenterol; 2003 Oct; 37(4):281-7. PubMed ID: 14506383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cyclooxygenase 2 inhibitors and adenomatous polyposis coli].
    Florent C; Meary N
    Bull Cancer; 2004 May; 91 Suppl 2():S85-8. PubMed ID: 15899631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemoprevention in colorectal neoplasias: what is practical and feasible?
    Ricciardiello L; Roda E; Bazzoli F
    Dig Dis; 2002; 20(1):70-2. PubMed ID: 12145422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levels of rectal mucosal polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma.
    Thompson PA; Wertheim BC; Zell JA; Chen WP; McLaren CE; LaFleur BJ; Meyskens FL; Gerner EW
    Gastroenterology; 2010 Sep; 139(3):797-805, 805.e1. PubMed ID: 20538001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological and dietary prevention for colorectal cancer.
    Nolfo F; Rametta S; Marventano S; Grosso G; Mistretta A; Drago F; Gangi S; Basile F; Biondi A
    BMC Surg; 2013; 13 Suppl 2(Suppl 2):S16. PubMed ID: 24267792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
    Sandler RS
    Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of NSAIDs for the chemoprevention of colorectal cancer.
    Herendeen JM; Lindley C
    Ann Pharmacother; 2003 Nov; 37(11):1664-74. PubMed ID: 14565811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoprevention of colorectal cancer: feasibility in everyday practice?
    Herszényi L; Farinati F; Miheller P; Tulassay Z
    Eur J Cancer Prev; 2008 Nov; 17(6):502-14. PubMed ID: 18941372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinations for cancer prevention.
    Gupta RA; DuBois RN
    Nat Med; 2000 Sep; 6(9):974-5. PubMed ID: 10973312
    [No Abstract]   [Full Text] [Related]  

  • 38. The future of colon cancer prevention.
    Umar A; Viner JL; Hawk ET
    Ann N Y Acad Sci; 2001 Dec; 952():88-108. PubMed ID: 11795446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemoprevention of colorectal cancer.
    Clapper ML; Chang WC; Meropol NJ
    Curr Opin Oncol; 2001 Jul; 13(4):307-13. PubMed ID: 11429490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folic acid and risk of prostate cancer: results from a randomized clinical trial.
    Figueiredo JC; Grau MV; Haile RW; Sandler RS; Summers RW; Bresalier RS; Burke CA; McKeown-Eyssen GE; Baron JA
    J Natl Cancer Inst; 2009 Mar; 101(6):432-5. PubMed ID: 19276452
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.